The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer
出版年份 2021 全文链接
标题
The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer
作者
关键词
-
出版物
Journal of Personalized Medicine
Volume 11, Issue 7, Pages 618
出版商
MDPI AG
发表日期
2021-06-30
DOI
10.3390/jpm11070618
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer
- (2021) Argun Akcakanat et al. CLINICAL CANCER RESEARCH
- A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors
- (2020) Sukhvir Kaur et al. BIOORGANIC & MEDICINAL CHEMISTRY
- GP130 Cytokines in Breast Cancer and Bone
- (2020) Tolu Omokehinde et al. Cancers
- EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
- (2020) K. Almstedt et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical Activity
- (2020) Luca Falzone et al. Cancers
- The impact of EndoPredict ® on decision making with increasing oncological work experience: can overtreatment be avoided?
- (2019) Fabinshy Thangarajah et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
- (2019) Ivana Sestak et al. BREAST CANCER RESEARCH AND TREATMENT
- Prediction of Distant Recurrence using EndoPredict among Women with ER+, HER2- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only
- (2019) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
- (2019) Masaaki Murakami et al. IMMUNITY
- Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study
- (2019) Daniel Herr et al. PLoS One
- The Regulatory Role of MicroRNAs in Breast Cancer
- (2019) Hui-Yi Loh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNAs in breast cancer: Roles, functions, and mechanism of actions
- (2019) Maryam Abolghasemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients
- (2018) Ryo Tsunashima et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
- (2018) Mustafa Yassin Taher et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
- (2018) Ali Masjedi et al. BIOMEDICINE & PHARMACOTHERAPY
- The evolving role of receptors as predictive biomarkers for metastatic breast cancer
- (2018) Carlos Martínez-Pérez et al. Expert Review of Anticancer Therapy
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
- (2017) M.J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2017) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profiles
- (2017) Sukhontip Klahan et al. TUMOR BIOLOGY
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
- (2017) Tomas Reinert et al. Frontiers in Oncology
- Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
- (2016) Richard Buus et al. JNCI-Journal of the National Cancer Institute
- Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
- (2016) Tae-Hwe Heo et al. Oncotarget
- Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
- (2016) Richard Buus et al. JNCI-Journal of the National Cancer Institute
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
- (2015) F Fitzal et al. BRITISH JOURNAL OF CANCER
- Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer
- (2015) Cameron N. Johnstone et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer
- (2015) Arran K. Turnbull et al. JOURNAL OF CLINICAL ONCOLOGY
- Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
- (2015) Yingbo Shao et al. PLoS One
- Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes
- (2015) Elana J. Fertig et al. Scientific Reports
- Novel genes associated with lymph node metastasis in triple negative breast cancer
- (2015) Andrea Mathe et al. Scientific Reports
- Gender-associated expression of tumor markers and a small gene set in breast carcinoma
- (2014) Sarah A. Andres et al. BREAST
- The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
- (2014) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer
- (2013) Y. Sota et al. ANNALS OF ONCOLOGY
- The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients
- (2013) P Dubsky et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
- (2013) Y. Zhang et al. CLINICAL CANCER RESEARCH
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions
- (2013) Berit Maria Müller et al. PLoS One
- Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test
- (2012) Ralf Kronenwett et al. BMC CANCER
- Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay
- (2012) Carsten Denkert et al. VIRCHOWS ARCHIV
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- gp130 at the nexus of inflammation, autoimmunity, and cancer
- (2010) J. S. Silver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
- (2009) C. H. Barrios et al. ANNALS OF ONCOLOGY
- OSM, LIF, Its Receptors, and Its Relationship with the Malignance in Human Breast Carcinoma (In Situand in Infiltrative)
- (2008) Ignacio García-Tuñón et al. CANCER INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now